The mechanisms linking the systemic influences of type 1 diabetes with endometrial hyperplasic and possibly endometrial cancer, or any other cancer, are not fully elucidated, but likely include both p16 and the ERα. The gene discussed is CDKN2A; the disease is type 1 diabetes mellitus.